• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail

Return to search Page to restart search Return to Orphan Designation Search Page Return to Search Page
Generic Name:  treprostinil
Trade Name:  Remodulin
Date Designated:  06/04/1997
Orphan Designation:  Treatment of pulmonary arterial hypertension.
Orphan Designation Status:  Designated/Approved
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
United Therapeutics Corp.
55 T.W. Alexander Dr.
Research Triangle Park, North Carolina 27709

The sponsor address listed is the last reported by the sponsor to OOPD.